What they were paid
TEVA PHARMACEUTICAL INDUSTRIES Director Compensation Table · all 3 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $145,000 | $249,987 | $0 | $0 | $394,987 |
| FY2024 | $175,000 | $159,988 | — | — | $334,988 |
| FY2023 | $165,459 | $159,999 | — | — | $325,458 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TEVA PHARMACEUTICAL INDUSTRIES LTD DEF 14A filed March 31, 2026, accession 0001193125-26-134756, and prior-year filings. Open the filing on EDGAR.
How this page was built: the TEVA PHARMACEUTICAL INDUSTRIES LTD filed document, accession 0001193125-26-134756. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2026.
Get the TEVA PHARMACEUTICAL INDUSTRIES Board Governance Report
$394,987 Janet S. Vergis, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of March 31, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025TEVA PHARMACEUTICAL INDUSTRIES pays directors a $100,000 cash retainer and $250,000 in RSUs.
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance · Compliance (Chair)
The rest of the TEVA PHARMACEUTICAL INDUSTRIES board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Amir Elstein | Independent Director | $392,487 |
| Chen Lichtenstein | Independent Director | $382,487 |
| Dr. Perry D. Nisen | Independent Director | $394,987 |
| Dr. Sol J. Barer | Chair of the Board | $599,998 |
| Dr. Tal Zaks | Independent Director | $374,987 |
| Gerald M. Lieberman | Independent Director | $414,987 |
| Prof. Ronit Satchi-Fainaro | Independent Director | $379,987 |
| Prof. Varda Shalev | Independent Director | $369,987 |
| Richard D. Francis | Director | — |
| Roberto A. Mignone | Independent Director | $399,987 |
| Rosemary A. Crane | Independent Director | $389,987 |
The full TEVA PHARMACEUTICAL INDUSTRIES compensation record
free company briefThis page is one director within TEVA PHARMACEUTICAL INDUSTRIES's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the TEVA PHARMACEUTICAL INDUSTRIES proxy · each links to its own free briefOrder TEVA
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.